Showing results (91-100 of 447) with videos related to
Sort By:
Pageof 45
Heart Rhythm O2|August 30, 2023
Ventricular tachycardia risk prediction with an abbreviated duration mobile cardiac telemetryJohan Economou Lundeberg, Alexandra Måneheim, Anders Persson, et al.The Canadian Journal of Cardiology|May 11, 2006
Stroke prevention in patients with atrial fibrillation: the diagnosis and management of hypertension by specialistsJeff S Healey, Sean Wharton, Saif Al-Kaabi, et al.American Heart Journal|February 22, 2003
Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) studyStuart J Connolly, Irene Cybulsky, André Lamy, et al.Journal of the American College of Cardiology|July 10, 2002
Historical criteria that distinguish syncope from seizuresRobert Sheldon, Sarah Rose, Debbie Ritchie, et al.JAMA|May 8, 2003
Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trialStuart J Connolly, Robert Sheldon, Kevin E Thorpe, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 9, 2019
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trialAiman Alak, Stefan H Hohnloser, Mandy Fräßdorf, et al.European Heart Journal|September 29, 2012
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapyMichiel Coppens, John W Eikelboom, Robert G Hart, et al.Stroke|April 12, 2012
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trialRobert G Hart, Hans-Christoph Diener, Sean Yang, et al.European Heart Journal|May 26, 2005
Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trialsYee Guan Yap, Trinh Duong, Martin Bland, et al.American Heart Journal|July 1, 2008
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)Jose Antonio Marin-Neto, Anis Rassi, Carlos A Morillo, et al.Pageof 45